Stock 4671 FALCO HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials FALCO HOLDINGS Co., Ltd.

Equities

4671

JP3802650006

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 07:00:00 26/06/2024 BST 		5-day change 1st Jan Change
2,296 JPY -0.04% Intraday chart for FALCO HOLDINGS Co., Ltd. -0.61% +9.96%
01-30 Tranche Update on FALCO HOLDINGS Co., Ltd.'s Equity Buyback Plan announced on August 10, 2023. CI
01-29 FALCO HOLDINGS Co., Ltd.'s Equity Buyback announced on August 10, 2023, has closed with 587,500 shares, representing 5.29% for ¥1,199.88 million. CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 14,890 18,686 18,131 20,974 20,617 24,953
Enterprise Value (EV) 1 9,558 14,923 12,417 14,399 10,815 15,705
P/E ratio 22.9 x 15.3 x 9.85 x 5.96 x 9.19 x 15.5 x
Yield 3.38% 2.71% 3.09% 2.79% 3.26% -
Capitalization / Revenue 0.34 x 0.43 x 0.42 x 0.42 x 0.44 x 0.58 x
EV / Revenue 0.22 x 0.35 x 0.28 x 0.29 x 0.23 x 0.37 x
EV / EBITDA 4.41 x 8.41 x 3.48 x 2.23 x 2.63 x 5.01 x
EV / FCF 12 x 47.1 x 11.8 x 7.37 x 31.7 x 7.28 x
FCF Yield 8.32% 2.12% 8.45% 13.6% 3.15% 13.7%
Price to Book 0.78 x 0.99 x 0.89 x 0.89 x 0.83 x 0.96 x
Nbr of stocks (in thousands) 10,948 10,551 10,367 10,451 10,487 10,673
Reference price 2 1,360 1,771 1,749 2,007 1,966 2,338
Announcement Date 21/06/19 23/06/20 22/06/21 22/06/22 23/06/23 21/06/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024
Net sales 1 44,156 43,185 43,608 50,007 46,913 43,007
EBITDA 1 2,165 1,775 3,568 6,461 4,117 3,132
EBIT 1 1,338 848 2,615 5,503 3,076 2,154
Operating Margin 3.03% 1.96% 6% 11% 6.56% 5.01%
Earnings before Tax (EBT) 1 1,203 1,850 2,891 5,567 3,694 2,571
Net income 1 653 1,243 1,853 3,533 2,261 1,666
Net margin 1.48% 2.88% 4.25% 7.07% 4.82% 3.87%
EPS 2 59.44 116.1 177.5 337.0 214.0 150.9
Free Cash Flow 1 795.6 316.6 1,049 1,954 340.6 2,158
FCF margin 1.8% 0.73% 2.41% 3.91% 0.73% 5.02%
FCF Conversion (EBITDA) 36.75% 17.84% 29.4% 30.25% 8.27% 68.91%
FCF Conversion (Net income) 121.84% 25.47% 56.61% 55.32% 15.07% 129.55%
Dividend per Share 2 46.00 48.00 54.00 56.00 64.00 -
Announcement Date 21/06/19 23/06/20 22/06/21 22/06/22 23/06/23 21/06/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 20,391 24,693 11,748 13,566 11,566 12,585 24,151 11,727 11,035 10,638 10,687 21,325 10,989 10,693
EBITDA - - - - - - - - - - - - - -
EBIT 1 712 3,136 658 1,702 681 1,060 1,741 768 566 249 602 851 592 709
Operating Margin 3.49% 12.7% 5.6% 12.55% 5.89% 8.42% 7.21% 6.55% 5.13% 2.34% 5.63% 3.99% 5.39% 6.63%
Earnings before Tax (EBT) 620 3,345 649 1,573 748 1,176 1,924 777 994 292 - 1,050 900 -
Net income 1 337 2,125 398 1,010 442 683 1,125 415 721 124 505 629 646 391
Net margin 1.65% 8.61% 3.39% 7.45% 3.82% 5.43% 4.66% 3.54% 6.53% 1.17% 4.73% 2.95% 5.88% 3.66%
EPS 32.47 204.4 37.94 - 42.32 - 107.5 39.38 - 11.07 - 56.29 58.75 -
Dividend per Share 24.00 28.00 - - - - 32.00 - - - - 40.00 - -
Announcement Date 05/11/20 09/11/21 08/02/22 13/05/22 05/08/22 08/11/22 08/11/22 08/02/23 12/05/23 10/08/23 08/11/23 08/11/23 09/02/24 10/05/24
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - - -
Net Cash position 1 5,332 3,763 5,714 6,575 9,802 9,248
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 796 317 1,049 1,955 341 2,158
ROE (net income / shareholders' equity) 3.43% 6.56% 9.41% 16.1% 9.03% 6.33%
ROA (Net income/ Total Assets) 2.58% 1.65% 4.74% 8.9% 4.86% 3.57%
Assets 1 25,292 75,147 39,130 39,715 46,543 46,604
Book Value Per Share 2 1,734 1,785 1,974 2,245 2,369 2,438
Cash Flow per Share 2 715.0 687.0 1,120 1,018 1,123 943.0
Capex 1 951 955 1,333 2,069 1,287 1,100
Capex / Sales 2.15% 2.21% 3.06% 4.14% 2.74% 2.56%
Announcement Date 21/06/19 23/06/20 22/06/21 22/06/22 23/06/23 21/06/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for FALCO HOLDINGS Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
FALCO HOLDINGS CO., LTD. Stock FALCO HOLDINGS Co., Ltd.
+9.96% 153M
RADNET, INC. Stock RadNet, Inc.
+64.34% 4.26B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+6.56% 2.71B
SYNLAB AG Stock SYNLAB AG
-2.10% 2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-57.14% 1.72B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-18.91% 1.67B
FLEURY S.A. Stock Fleury S.A.
-20.73% 1.45B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+15.38% 1.19B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-50.40% 1.01B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+12.39% 948M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 4671 Stock
  4. Financials FALCO HOLDINGS Co., Ltd.